(MedPage Today) — The FDA approved sepiapterin (Sephience) for the treatment of children and adults with phenylketonuria (PKU), PTC Therapeutics announced.
The approval includes broad labeling for the treatment of hyperphenylalaninemia in adult…
Source link : https://www.medpagetoday.com/genetics/generalgenetics/116718
Author :
Publish date : 2025-07-29 16:33:00
Copyright for syndicated content belongs to the linked Source.
